Navigation Links
Watson Confirms Columbia Laboratories Shareholder Approval of Proposed Acquisition of Progesterone-related Assets
Date:7/1/2010

erway to evaluate the safety and efficacy of PROCHIEVE® 8% (progesterone gel) to reduce the risk of pre-term birth in women with a cervical length between 1.0 and 2.0 centimeters as measured by transvaginal ultrasound at mid-pregnancy. The primary endpoint of this study is a reduction in the incidence of pre-term birth at less than or equal to 32 weeks gestation vs. placebo.  With enrollment in the program complete, preliminary top-line study results are expected at the end of 2010. If the data are positive, a NDA filing will follow in 2011. Pre-term birth occurs in one of every eight live born infants, and short cervix is the single most important predictor of pre-term birth.  There are currently no products approved for the prevention of pre-term birth.

Important Safety Information

The most common side effects of CRINONE® include breast enlargement, constipation, somnolence, nausea, headache, and perineal pain.  CRINONE® is contraindicated in patients with active thrombophlebitis or thromboembolic disorders, or a history of hormone-associated thrombophlebitis or thromboembolic disorders, missed abortion, undiagnosed vaginal bleeding, liver dysfunction or disease, and known or suspected malignancy of the breast or genital organs.

About Watson Pharmaceuticals, Inc.

Watson Pharmaceuticals, Inc. is a leading global specialty pharmaceutical company.  Watson is engaged in the development and distribution of generic pharmaceuticals and specialized branded pharmaceutical products focused on Urology and Women's Health.  Watson has operations in many of the world's established and growing international markets.

In the U.S., the Watson Brand portfolio includes RAPAFLO®, GELNIQUE®, Oxytrol®, TRELSTAR® and INFeD®.  In addition, Watson ma
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Watson Launches Generic Biaxin(R) XL
2. Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder
3. Watson Announces Silodosin NDA Accepted for Filing by FDA for the Treatment of Benign Prostatic Hyperplasia
4. Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder
5. Watson Announces United States Availability of RAPAFLO(TM) (silodosin), a Novel New Treatment in Benign Prostatic Hyperplasia (BPH)
6. Watson and Barr Settle Lawsuit Over Oxytrol(R)
7. Watson to Host Conference Call and Webcast to Discuss Fourth Quarter 2009 Earnings and 2010 Outlook
8. Watson Completes Acquisition of Eden Biodesign
9. Watson to Present at Credit Suisse Healthcare Conference
10. Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy
11. Watson Files FDA Application for Generic Rozerem(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... 2015   Cynosure, Inc. (Nasdaq: CYNO ... aesthetic procedures and precision surgical applications worldwide, today reported ... 2015. First-Quarter Highlights: , North America ... earnings of $0.15 per share; GAAP earnings break-even ... 31, 2015 "Cynosure delivered 21 percent year-over-year ...
(Date:5/5/2015)...  Astellas announced that two abstracts detailing clinical data ... data from a study of mirabegron as an add-on ... breaking plenary session at the 2015 annual meeting of ... New Orleans, Louisiana . ... to evaluate enzalutamide compared to bicalutamide in metastatic prostate ...
(Date:5/5/2015)... 5, 2015  AMRI (NASDAQ: AMRI ) today reported ... 31, 2015. Highlights: , First quarter ... , First quarter royalties of $6.7 million, down ... diluted EPS of $0.20 up 25% from $0.16 in 2014, ... current quarter , Completed the acquisitions of ...
Breaking Medicine Technology:Cynosure Announces First-Quarter 2015 Results; Posts Record First-Quarter Revenue of $74.9 Million, Up 21 Percent from Prior Year 2Cynosure Announces First-Quarter 2015 Results; Posts Record First-Quarter Revenue of $74.9 Million, Up 21 Percent from Prior Year 3Cynosure Announces First-Quarter 2015 Results; Posts Record First-Quarter Revenue of $74.9 Million, Up 21 Percent from Prior Year 4Cynosure Announces First-Quarter 2015 Results; Posts Record First-Quarter Revenue of $74.9 Million, Up 21 Percent from Prior Year 5Cynosure Announces First-Quarter 2015 Results; Posts Record First-Quarter Revenue of $74.9 Million, Up 21 Percent from Prior Year 6Cynosure Announces First-Quarter 2015 Results; Posts Record First-Quarter Revenue of $74.9 Million, Up 21 Percent from Prior Year 7Cynosure Announces First-Quarter 2015 Results; Posts Record First-Quarter Revenue of $74.9 Million, Up 21 Percent from Prior Year 8Cynosure Announces First-Quarter 2015 Results; Posts Record First-Quarter Revenue of $74.9 Million, Up 21 Percent from Prior Year 9Cynosure Announces First-Quarter 2015 Results; Posts Record First-Quarter Revenue of $74.9 Million, Up 21 Percent from Prior Year 10Cynosure Announces First-Quarter 2015 Results; Posts Record First-Quarter Revenue of $74.9 Million, Up 21 Percent from Prior Year 11Astellas Announces New Data To Be Presented During Late Breaking Plenary Session At AUA Annual Meeting 2Astellas Announces New Data To Be Presented During Late Breaking Plenary Session At AUA Annual Meeting 3Astellas Announces New Data To Be Presented During Late Breaking Plenary Session At AUA Annual Meeting 4Astellas Announces New Data To Be Presented During Late Breaking Plenary Session At AUA Annual Meeting 5Astellas Announces New Data To Be Presented During Late Breaking Plenary Session At AUA Annual Meeting 6Astellas Announces New Data To Be Presented During Late Breaking Plenary Session At AUA Annual Meeting 7Astellas Announces New Data To Be Presented During Late Breaking Plenary Session At AUA Annual Meeting 8Astellas Announces New Data To Be Presented During Late Breaking Plenary Session At AUA Annual Meeting 9AMRI Announces First Quarter 2015 Results 2AMRI Announces First Quarter 2015 Results 3AMRI Announces First Quarter 2015 Results 4AMRI Announces First Quarter 2015 Results 5AMRI Announces First Quarter 2015 Results 6AMRI Announces First Quarter 2015 Results 7AMRI Announces First Quarter 2015 Results 8AMRI Announces First Quarter 2015 Results 9AMRI Announces First Quarter 2015 Results 10AMRI Announces First Quarter 2015 Results 11AMRI Announces First Quarter 2015 Results 12AMRI Announces First Quarter 2015 Results 13AMRI Announces First Quarter 2015 Results 14AMRI Announces First Quarter 2015 Results 15AMRI Announces First Quarter 2015 Results 16
... SUNNYVALE, Calif., Dec. 22 Arrayit Corporation (OTC Bulletin Board: ... that the Company has made a technological breakthrough in the ... which are tiny glass substrates that contain rows and columns ... The advance allows highly precise printing of as many as ...
... , NEW YORK, Dec. 22 Delcath Systems, Inc. (Nasdaq: ... treatment method for primary and metastatic cancers to the liver, ... Scientific Advisory Board, effective immediately. , "We formed our ... our Delcath PHP System(TM) with insight from the leading experts ...
Cached Medicine Technology:Arrayit Corporation Announces Manufacturing Breakthrough 2Arrayit Corporation Announces Manufacturing Breakthrough 3Professor Riccardo Lencioni Joins Delcath Systems' Scientific Advisory Board 2Professor Riccardo Lencioni Joins Delcath Systems' Scientific Advisory Board 3
(Date:5/5/2015)... Sheltering Arms held its annual benefit ... and Cravath, Swaine & Moore LLP for their philanthropic ... event was co-chaired by Vanguard sponsors Morgan Stanley and ... highlighted Sheltering Arms’ significant growth in New York City ... 2015. Formerly Episcopal Social Services, Sheltering Arms has become ...
(Date:5/5/2015)... 05, 2015 Buckeye Health Plan (BHP) ... CEO and plan president of Buckeye Health Plan. Hill, ... position immediately. , Hill has more than 28 years ... Pacific Northwest, from managed care to large health care ... CEO of HealthPlus of Michigan, a health plan serving ...
(Date:5/5/2015)... NovaSom, Inc., announced today that they will ... Ed Begley Jr., airing via Discovery Channel 3rd QTR ... will focus on NovaSom, a leader in Obstructive Sleep ... AccuSom® home sleep test, which is the only comprehensively ... and next-day test results and interpretation. , ...
(Date:5/5/2015)... After record-breaking sales of Extend Nutrition’s ... Cookies & Cream flavor at stores nationwide this month. ... raised the bar for nutritional snacks. The brand ... nutritional profile, backed by international patents and clinical studies. ... additional new products and expand retail availability throughout 2015. ...
(Date:5/5/2015)... May 05, 2015 After conducting a ... solutions firm B. E. Smith, West Holt Medical ... as chief executive officer. A skilled healthcare executive with ... assume his new duties on June 1st. , “Brad ... well as a keen understanding and success in building ...
Breaking Medicine News(10 mins):Health News:Sheltering Arms Honors Walt "Clyde" Frazier and Cravath, Swaine & Moore LLP at Annual Gala 2Health News:Buckeye Health Plan Announces New Chief Executive Officer 2Health News:Buckeye Health Plan Announces New Chief Executive Officer 3Health News:Innovations with Ed Begley, Jr. to Explore NovaSom, Inc., in Upcoming Episode 2Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 2Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 3Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 4Health News:West Holt Medical Services Hires New Chief Executive Officer 2Health News:West Holt Medical Services Hires New Chief Executive Officer 3
... regain pre-pregnancy body, IRVINE, Calif., Aug. ... post-baby body shaping solution VelaShape(TM),and other medical ... today reveals the results of the VelaShape ... desire to regain their,pre-pregnancy body. Syneron commissioned ...
... host roundtable discussion as part of national ... Campaign for an American Solution, SALT LAKE ... Utah small business owners at a,roundtable discussion on health care issues ... the health insurance industry,s Campaign for,an American Solution, a new national ...
... Gerianne Tringali DiPiano,President, CEO and founder of FemmePharma in ... healthcare executives and one of the top 12 entrepreneurs ... DiPiano is one of only two women., PharmaVOICE ... has not only carved out a niche in the ...
... Texas Mutual Insurance Company,(TMIC) said it would appeal ... the 14th Court of Appeals., The 14th Court ... a,district court in Harris County found TMIC acted in ... insurance code. The jury also had found,that plaintiff P. ...
... for diabetes , , WEDNESDAY, Aug. 27 (HealthDay News) -- Scientists ... insulin-producing beta cells, a feat they call an "extreme makeover." ... or even a cure for both type 1 and type ... production or uptake. , The process, reported online Aug. 27 ...
... Tacoma, Wash. August 27, 2008 Two new ... U.S. military personnel, yet the condition is frequently underdiagnosed. ... journal of the American Headache Society, examine the incidence ... 1-year combat tour in Iraq , as well as ...
Cached Medicine News:Health News:Celebrity Moms' Post-Baby Body Triggers Jealousy, Skepticism in U.S. Moms 2Health News:Celebrity Moms' Post-Baby Body Triggers Jealousy, Skepticism in U.S. Moms 3Health News:Celebrity Moms' Post-Baby Body Triggers Jealousy, Skepticism in U.S. Moms 4Health News:Health Insurance Industry Listens to Health Care Concerns of Utah Small Business Owners 2Health News:Health Insurance Industry Listens to Health Care Concerns of Utah Small Business Owners 3Health News:Texas Mutual Insurance to Appeal 14th Court's Decision to Texas Supreme Court 2Health News:Texas Mutual Insurance to Appeal 14th Court's Decision to Texas Supreme Court 3Health News:Texas Mutual Insurance to Appeal 14th Court's Decision to Texas Supreme Court 4Health News:Pancreatic Cells Turned Into Insulin-Producing Beta Cells 2Health News:Pancreatic Cells Turned Into Insulin-Producing Beta Cells 3Health News:Army personnel show increased risk for migraine 2
Singe-pull lace design provides easy-on application to provide support and immobilization of the wrist while preserving finger mobility...
ManuTrain is an active wrist support that has optional features for increased stabilization....
... Bird and Cronin, Inc. ... of Patient Footwear, Orthopedic ... Care Products. Our products ... quality and available in ...
... 3-Point® Polycentric Hinged Ulnar Deviation Splint uses ... the hand with ulnar deviation at the ... grasp or pinch. Radial and ulnar polycentric ... unimpeded flexion and extension. Padded, malleable finger ...
Medicine Products: